Literature DB >> 31250731

The ANKS1B gene and its associated phenotypes: focus on CNS drug response.

Rabha M Younis1, Rachel M Taylor2, Patrick M Beardsley3,4, Joseph L McClay1.   

Abstract

The ANKS1B gene was a top finding in genome-wide association studies (GWAS) of antipsychotic drug response. Subsequent GWAS findings for ANKS1B include cognitive ability, educational attainment, body mass index, response to corticosteroids and drug dependence. We review current human association evidence for ANKS1B, in addition to functional studies that include two published mouse knockouts. The several GWAS findings in humans indicate that phenotypically relevant variation is segregating at the ANKS1B locus. ANKS1B shows strong plausibility for involvement in CNS drug response because it encodes a postsynaptic effector protein that mediates long-term changes to neuronal biology. Forthcoming data from large biobanks should further delineate the role of ANKS1B in CNS drug response.

Entities:  

Keywords:  BMI; NMDA; antipsychotics; cognition; corticosteroids; drugs of abuse; glutamatergic neurotransmission; postsynaptic density; serotonin; synapse to nucleus communication; synaptic plasticity

Mesh:

Substances:

Year:  2019        PMID: 31250731      PMCID: PMC6912848          DOI: 10.2217/pgs-2019-0015

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  88 in total

1.  Genetic predictors of antipsychotic response to lurasidone identified in a genome wide association study and by schizophrenia risk genes.

Authors:  Jiang Li; Akane Yoshikawa; Mark D Brennan; Timothy L Ramsey; Herbert Y Meltzer
Journal:  Schizophr Res       Date:  2017-04-19       Impact factor: 4.939

2.  A Large Multiethnic Genome-Wide Association Study of Adult Body Mass Index Identifies Novel Loci.

Authors:  Thomas J Hoffmann; Hélène Choquet; Jie Yin; Yambazi Banda; Mark N Kvale; Maria Glymour; Catherine Schaefer; Neil Risch; Eric Jorgenson
Journal:  Genetics       Date:  2018-08-14       Impact factor: 4.562

3.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

Authors:  Jeffrey A Lieberman; T Scott Stroup; Joseph P McEvoy; Marvin S Swartz; Robert A Rosenheck; Diana O Perkins; Richard S E Keefe; Sonia M Davis; Clarence E Davis; Barry D Lebowitz; Joanne Severe; John K Hsiao
Journal:  N Engl J Med       Date:  2005-09-19       Impact factor: 91.245

4.  Gating and habituation of the startle reflex in schizophrenic patients.

Authors:  D L Braff; C Grillon; M A Geyer
Journal:  Arch Gen Psychiatry       Date:  1992-03

5.  Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.

Authors:  Joseph L McClay; Daniel E Adkins; Karolina Aberg; Jozsef Bukszár; Amit N Khachane; Richard S E Keefe; Diana O Perkins; Joseph P McEvoy; T Scott Stroup; Robert E Vann; Patrick M Beardsley; Jeffrey A Lieberman; Patrick F Sullivan; Edwin J C G van den Oord
Journal:  Neuropsychopharmacology       Date:  2010-11-24       Impact factor: 7.853

Review 6.  Classification and basic pathology of Alzheimer disease.

Authors:  Charles Duyckaerts; Benoît Delatour; Marie-Claude Potier
Journal:  Acta Neuropathol       Date:  2009-04-21       Impact factor: 17.088

7.  Explorative results from multistep screening for potential genetic risk loci of Alzheimer's disease in the longitudinal VITA study cohort.

Authors:  Claus-Jürgen Scholz; Heike Weber; Susanne Jungwirth; Walter Danielczyk; Andreas Reif; Karl-Heinz Tragl; Peter Fischer; Peter Riederer; Jürgen Deckert; Edna Grünblatt
Journal:  J Neural Transm (Vienna)       Date:  2017-10-12       Impact factor: 3.575

8.  Post-zygotic genomic changes in glutamate and dopamine pathway genes may explain discordance of monozygotic twins for schizophrenia.

Authors:  C A Castellani; M G Melka; J L Gui; A J Gallo; R L O'Reilly; S M Singh
Journal:  Clin Transl Med       Date:  2017-11-28

9.  Genome-wide prediction and analysis of human tissue-selective genes using microarray expression data.

Authors:  Shaolei Teng; Jack Y Yang; Liangjiang Wang
Journal:  BMC Med Genomics       Date:  2013-01-23       Impact factor: 3.063

10.  Calcium Signaling Pathway Is Associated with the Long-Term Clinical Response to Selective Serotonin Reuptake Inhibitors (SSRI) and SSRI with Antipsychotics in Patients with Obsessive-Compulsive Disorder.

Authors:  Hidehiro Umehara; Shusuke Numata; Atsushi Tajima; Akira Nishi; Masahito Nakataki; Issei Imoto; Satsuki Sumitani; Tetsuro Ohmori
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

View more
  2 in total

1.  Epigenomic Changes after Acupuncture Treatment in Patients Suffering from Burnout.

Authors:  Marc Petitpierre; Ludwig Stenz; Ariane Paoloni-Giacobino
Journal:  Complement Med Res       Date:  2021-12-07       Impact factor: 1.449

2.  The Effect of Sleep Deprivation and Subsequent Recovery Period on the Synaptic Proteome of Rat Cerebral Cortex.

Authors:  Péter Gulyássy; Katalin Todorov-Völgyi; Vilmos Tóth; Balázs A Györffy; Gina Puska; Attila Simor; Gábor Juhász; László Drahos; Katalin Adrienna Kékesi
Journal:  Mol Neurobiol       Date:  2022-01-05       Impact factor: 5.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.